Results 191 to 200 of about 2,408,361 (302)

Scaling genomic reanalysis to unlock diagnoses and transform rare disease care. [PDF]

open access: yesHGG Adv
Rockowitz S   +47 more
europepmc   +1 more source

Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Narcolepsy type 1 (NT1) is caused by the loss of hypocretin‐1 leading to excessive daytime sleepiness and cataplexy. Additionally, disrupted nighttime sleep has become an increasingly recognized feature of NT1. As the glymphatic fluid movement has been linked to sleep architecture, we investigated cerebrospinal fluid (CSF) Aquaporin‐4 (AQP4 ...
Jonas Ranke   +5 more
wiley   +1 more source

Rare Diseases [PDF]

open access: yesFuture Medicinal Chemistry, 2014
openaire   +1 more source

Case Report of Andersen-Tawil Syndrome: Rare Presentation of a Rare Disease. [PDF]

open access: yesAnn Indian Acad Neurol
Shakya H   +4 more
europepmc   +1 more source

A Case of Cerebral Cortical Encephalitis

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Sixiao Liu, Kunqian Ji, Wei Wu, Wei Li
wiley   +1 more source

Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez   +10 more
wiley   +1 more source

KLINSE: a comprehensive service model for rare disease information and care management support. [PDF]

open access: yesOrphanet J Rare Dis
Jäger K   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy